← Back to all trials
Completed
NCT06616909
Advance Care Planning Impact on the Consistency of Older Adults With Lung Cancer and Their Potential Surrogates Regarding Life-Sustaining Treatment Preferences
Conditions: Advanced Care Planning (ACP), ELDERLY PEOPLE, Lung Cancer (NSCLC)
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 124
Sponsor: National Taiwan University Hospital
Location: National Taiwan University Hospital Taipei
Summary
This randomized controlled trial examined whether an advance care planning (ACP) tabletop game ("Walking with Wishes") could improve the consistency of life-sustaining treatment preferences between older adults with lung cancer and their potential surrogates (family members or friends), compared to a standard ACP manual. Eligible dyads (patient-surrogate pairs) were randomized 1:1 to either the tabletop game intervention or the ACP manual control group. The primary outcome was the absolute gap score on the modified Life Support Preferences Questionnaire (m-LSPQ), measuring the difference between patient and surrogate preferences for five life-sustaining treatments (antibiotics, CPR, surgery, nasogastric tube feeding, and intravenous infusion) across nine health scenarios. Secondary outcomes included state anxiety (STAI-S) for both patients and surrogates. The m-LSPQ was assessed at baseline (T0), 2 weeks (T2), and 6 weeks (T3) post-intervention. The STAI-S was additionally assessed immediately post-intervention (T1) to capture acute emotional responses to the intervention.
Eligibility Criteria
Inclusion Criteria:
1. lung cancer age ≧ 60
2. The elderly with lung cancer are conscious and have no severe visual or hearing impairment.
3. The potential surrogate was designated by the older adult with lung cancer as the person who may make medical decisions in the future. The potential surrogate must be at least 18 years old.
Exclusion Criteria:
1. People with severe hearing loss and visual impairment who are unable to communicate in Mandarin and Taiwanese.
2. The potential agent is under 18 years old
Source: ClinicalTrials.gov (NCT06616909). StuddyBuddy aggregates publicly available trial information.